Tehy President Millariikka Rytkönen says that HUS initiated its cooperation negotiation process without appropriate preparations and an overall plan. HUS’s proposals have been inadequate, and HUS has failed to appropriately take into account the impacts of the cuts made in different areas on different divisions.
There is also a glaring absence of an assessment of the overall impacts of the cooperation negotiations. It is unclear whether HUS is planning to carry out such an assessment at all.
Tehy’s professional branches have submitted three information requests to HUS in order to obtain more information about the employer’s plans, but HUS has not provided all the information requested. Instead, HUS has simply said ‘no’ or stated that it will get back to the matter in the next phase of the negotiations.
– Unfortunately, HUS is not interested in providing its employees with realistic information to serve as the basis for discussions. This is very detrimental to the staff,” Millariikka Rytkönen comments.
Tehy is also critical of HUS’s interpretation of the Co-operation Act. Right at the beginning of the cooperation negotiations, Tehy’s assessment was that HUS was violating the Co-operation Act, as it failed to provide appropriate information about the negotiations and hear its staff.
As the cooperation negotiations have gone on, these concerns have only increased. The big question is whether the staff’s participation rights prescribed in the Co-operation Act are being fulfilled at all in these nebulous conditions created by HUS.
– The whole thing is very confusing. For example, the figures provided by the employer are not true. Because of this, it is hard to take the figures presented seriously,” Rytkönen concludes.
All in all, HUS’s proposals this far have formed something of an undefined patchwork. At this point, a significant portion of the dismissals planned in the cooperation negotiations appear to be targeting clinical patient work, which inevitably raises the question of how these decisions will impact the availability of care and patient safety.
Enquiries: Specialist, lawyer Jarkko Pehkonen, [email protected], tel. +358 40 531 5464